Tick galectin

Details Tick galectin Tick galectin

2009-04-21

2011-11-15

Long, Scott (Department: 1633)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C514S04400A, C514S004500, C514S004600

Reexamination Certificate

active

08057801

ABSTRACT:
A novel galectin, a polynucleotide encoding the same, a vector and a transformant comprising the polynucleotide, an antibody against the galectin, and a screening method for screening a substance capable of modifying the galectin, are disclosed. According to the galectin, polynucleotide, or vector, it is possible, for example, to exterminate ticks, or to treat or prevent tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis.

REFERENCES:
patent: 7135552 (2006-11-01), Fujisaki et al.
patent: 03072609 (2003-09-01), None
Mulenga et al (2002) Seq and Alignment.
Yagi et al, Glycoconjugate Journal, 18:745-749 (2001).
Astigarraga et al, Veterinary Parasitology, 60:133-147 (1995).
Hill et al, EMBL-EBI, Database Accession No. BF007251, XP-002328634 (Oct. 14, 2000).
Hill et al, Microbial & Comparative Genomics, 5:89-101 (2000).
Kovar et al, Biochem. Mol. Biol., 30(3):195-205 (2000).
Grubhoffer et al, Zool. Sci., 8(6):1001-1003 (1991).
Keller et al, Journal of Biological Chemistry, 268(8):5450-5456 (1993).
Rego et al, Insect Biochemistry and Molecular Biology, 36(4):291-299 (2006).

Affiliated with

Also associated with

Rating

Tick galectin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tick galectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tick galectin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4281622